Lisinopril photo
Pro Research Analysisby 
Searched over 200M research papers for "lisinopril photo"
Consensus Meter
Lisinopril: Clinical Applications and Effects
Lisinopril and Retinopathy in Type 1 Diabetes
Retinopathy Progression Reduction
Lisinopril, an ACE inhibitor, has shown potential in reducing the progression of retinopathy in normotensive patients with type 1 diabetes. A study involving retinal photographs over a 2-year period demonstrated that patients on lisinopril experienced a 50% reduction in retinopathy progression compared to those on placebo. This effect was consistent even after adjusting for glycemic control and other variables, suggesting that lisinopril could be beneficial in managing diabetic retinopathy.
Lisinopril and ACE2 Expression
Impact on SARS-CoV-2 Receptor
Research on healthy mice indicates that oral lisinopril increases tissue levels of ACE2, the receptor for SARS-CoV-2, across various organs including the lungs, kidneys, and brain. This finding is significant as it suggests that lisinopril could potentially influence the transmission and pathogenesis of COVID-19. Interestingly, the combination of lisinopril with losartan did not increase ACE2 levels, highlighting a complex interaction between these medications.
Lisinopril in Acute Myocardial Infarction
Mortality and Morbidity Reduction
Lisinopril has been extensively studied for its efficacy in the early management of acute myocardial infarction (AMI). The GISSI-3 trial, which included over 19,000 patients, demonstrated that lisinopril, when administered within 24 hours of symptom onset, significantly reduced mortality and severe left ventricular dysfunction. This benefit was observed across various patient demographics, including high-risk groups such as the elderly and those with diabetes .
Specific Benefits for Diabetic Patients
In diabetic patients with acute MI, lisinopril treatment was associated with a notable reduction in 6-week mortality rates compared to non-diabetic patients. This suggests that early intervention with lisinopril can be particularly beneficial for diabetic individuals, who are at higher risk of adverse outcomes following an MI.
Lisinopril in Congestive Heart Failure
Improvement in Cardiac Function
Lisinopril has also been shown to improve exercise duration, left ventricular ejection fraction (LVEF), and overall clinical symptoms in patients with congestive heart failure (CHF) . Comparative studies indicate that lisinopril is as effective as other ACE inhibitors like captopril, with some advantages in patients with renal impairment.
Lisinopril and Renal Disease in Diabetes
Influence of ACE Gene Polymorphism
The EURODIAB Controlled Trial of Lisinopril in IDDM explored the impact of ACE gene polymorphism on renal disease progression in diabetic patients. The study found that patients with the II genotype showed the most significant reduction in albumin excretion rate (AER) when treated with lisinopril, suggesting a genotype-specific response to ACE inhibition. This highlights the potential for personalized medicine approaches in managing diabetic nephropathy.
Conclusion
Lisinopril is a versatile ACE inhibitor with proven benefits in various clinical settings, including the management of retinopathy in type 1 diabetes, reduction of mortality and morbidity in acute myocardial infarction, and improvement of cardiac function in congestive heart failure. Additionally, its impact on ACE2 expression and potential genotype-specific effects in renal disease underscore the importance of further research to optimize its use in diverse patient populations.
Sources and full results
Most relevant research papers on this topic